Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Cyclophosphamide in Diffuse large B-cell lymphoma refractory: NCT06091865 Clinical Landscape Report 2026
16 October 2026
NCT06091865 clinical landscape for Diffuse large B-cell lymphoma refractory: endpoints, sponsor, phase, geography, readouts, asset context and development wh…
9 min read
DS-3032 in Solid tumor: NCT06090318 Clinical Landscape Report 2026
16 October 2026
NCT06090318 clinical landscape for Solid tumor: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ARI-0003 in High grade B-cell lymphoma: NCT06097455 Clinical Landscape Report 2026
16 October 2026
NCT06097455 clinical landscape for High grade B-cell lymphoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
DH-001 in Arrhythmias, Cardiac: NCT06092606 Clinical Landscape Report 2026
16 October 2026
NCT06092606 clinical landscape for Arrhythmias, Cardiac: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Peptide vaccine IPX(University Hospital Tuebingen) in Rhabdomyosarcoma: NCT06094101 Clinical Landscape Report 2026
16 October 2026
NCT06094101 clinical landscape for Rhabdomyosarcoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
AWT-020 in Sarcoma: NCT06092580 Clinical Landscape Report 2026
16 October 2026
NCT06092580 clinical landscape for Sarcoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Herombopag Olamine in Female Genital Neoplasms: NCT06099925 Clinical Landscape Report 2026
16 October 2026
NCT06099925 clinical landscape for Female Genital Neoplasms: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Pembrolizumab/Hyaluronidase in Melanoma, Cutaneous Malignant: NCT06099782 Clinical Landscape Report 2026
16 October 2026
NCT06099782 clinical landscape for Melanoma, Cutaneous Malignant: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Enzalutamide in Triple Negative Breast Cancer: NCT06099769 Clinical Landscape Report 2026
16 October 2026
NCT06099769 clinical landscape for Triple Negative Breast Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Carboplatin in Advanced Endometrial Carcinoma: NCT06102252 Clinical Landscape Report 2026
16 October 2026
NCT06102252 clinical landscape for Advanced Endometrial Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Atorvastatin Calcium in Endometrioid intraepithelial neoplasia: NCT06102863 Clinical Landscape Report 2026
16 October 2026
NCT06102863 clinical landscape for Endometrioid intraepithelial neoplasia: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
Axicabtagene Ciloleucel in Large B-cell lymphoma: NCT06104592 Clinical Landscape Report 2026
16 October 2026
NCT06104592 clinical landscape for Large B-cell lymphoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.